Africa News Guide: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Guide.

Press releases published on August 27, 2026

Google Premier Partner in South Africa: Top Click in Top 3%
SplashBI Unveils New Positioning as The Enterprise-Grade Data Intelligence Platform
Global Leaders Unite in Kenya for Historic Convening to Help End FGM/C and Child Marriage
OSNER’S FC Welcomes Ivorian Defender Ishmaël Coulibaly to Brooklyn
Accops Teams Up with Lithe SD to Strengthen Secure Digital Workspace Delivery Across IOC and ROA
Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™
XS.com Anuncia a promoção de Despina Iapona a Diretora de Marca do Grupo
XT Exchange Becomes the World's Only CEX Offering Hyperliquid Smart Money Copy Trading
Greenland Mines Set to Close Sarfartoq Rare Earths Acquisition by Sept. 1, 2026
AIM ImmunoTech Participates in the Virtual Investor ‘Why Now’ On-Demand Conference
Outlook Therapeutics CEO, Bob Jahr, Participates in the Virtual Investor “Why Now” On-Demand Conference
GRI Bio Featured in "Why Now" On-Demand Video Webcast
Codexis to Participate in Cantor Global Healthcare Conference 2026
Ambros Therapeutics Announces Appointments of John C. Jacobs and Scott Robertson to Board of Directors
Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
GoldHaven Commences Maiden Drill Program at Magno Project, Targeting Historic Kuhn Tungsten Zone
Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes
Cardurion Pharmaceuticals Announces Late-Breaking Presentation of Phase 2 Results for Tovinontrine (CRD-750), a PDE9 Inhibitor, in Heart Failure
HPQ and Novacium Deliver Custom-Configured Battery Packs to Three European Drone Manufacturers for Final-Stage Evaluation
Rectify Pharmaceuticals Presents Discovery of Clinical Candidate RTY-406, a Novel Disease-Modifying Therapy for the Treatment of PSC at ACS Fall 2026 Meeting

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Africa News Guide

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.